William S Reardon's Net Worth
$11.9 Million
Who is William S Reardon?
William S Reardon has an estimated net worth of $11.9 Million. This is based on reported shares across multiple companies, which include SYNTA PHARMACEUTICALS CORP, H&Q HEALTHCARE INVESTORS, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund, H&Q LIFE SCIENCES INVESTORS, HYBRIDON INC, and OSCIENT PHARMACEUTICALS CORP.
SEC CIK
William S Reardon's CIK is 0001212646
Past Insider Trading and Trends
2004 was William S Reardon's most active year for acquiring shares with 12 total transactions. William S Reardon's most active month to acquire stocks was the month of June. 2004 was William S Reardon's most active year for disposing of shares, totalling 2 transactions. William S Reardon's most active month to dispose stocks was the month of March. 2013 saw William S Reardon paying a total of $74,641.80 for 100,894 shares, this is the most they've acquired in one year. In 2004 William S Reardon cashed out on 44,157 shares for a total of $230,499.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $243.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.19% | 7.95K |
—
|
—
| 49.39K |
Jul 1
| |||
Form 4
| +13.34% | 4.88K |
—
|
—
| 41.44K |
Jul 1
| |||
Form 4
| +57.40% | 13.33K |
$3.75 | $49,998.75 | 36.56K |
Nov 13
| |||
Form 4
| +20.80% | 4K |
—
|
—
| 23.23K |
Jul 1
| |||
Form 4
| +35.40% | 5.03K |
—
|
—
| 19.23K |
Jul 1
| |||
Form 4
| +16.05% | 1.96K |
—
|
—
| 14.2K |
Jul 1
| |||
Form 4
| +46.10% | 3.86K |
—
|
—
| 12.24K |
Jul 1
| |||
Form 4
| +100.62% | 4.2K |
—
|
—
| 8.38K |
Jul 1
| |||
Form 4
| +47.74% | 1.35K |
—
|
—
| 4.17K |
Jun 11
| |||
Form 4
| +74.23% | 1.2K |
—
|
—
| 2.83K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
H&Q HEALTHCARE INVESTORS (HQH) Snapshot price: $18.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +101.92% | 742 |
$25.04 | $18,577.45 | 1.47K |
Jun 24
| |||
Form 4
|
∞
| 646 |
$15.86 | $10,242.39 | 646 |
Mar 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tekla Healthcare Opportunities Fund (THQ) Snapshot price: $21.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.2K |
$20.85 | $24,936.60 | 1.2K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tekla World Healthcare Fund (THW) Snapshot price: $12.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.29% | 486 |
$14.26 | $6,931.33 | 1.95K |
Apr 6
| |||
Form 4
|
∞
| 1.46K |
$17.14 | $25,024.40 | 1.46K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
H&Q LIFE SCIENCES INVESTORS (HQL) Snapshot price: $14.231
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.16% | 200 |
$19.75 | $3,950.00 | 1.61K |
Jun 30
| |||
Form 4
| +69.30% | 578 |
$19.75 | $11,415.50 | 1.41K |
Jun 24
| |||
Form 4
|
∞
| 772 |
$13.27 | $10,241.35 | 772 |
Mar 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |